H.R. 7693 explained  ·  119th Congress  ·  Pending in Congress

Leo’s Law

Create a free account or sign in to follow H.R. 7693 and get alerts. Policy area: Health Create a free account or sign in to follow the Health policy area and get alerts. ▲ 236 days since action Sponsor: Josh Gottheimer, NJ-05, D → Congress.gov

Cosponsors: 1 (0 D, 1 R) · per Congress.gov, 2026-10-09

Introduced: 2026-02-25

Latest action (2026-02-25): Referred to the House Committee on Energy and Commerce.

What H.R. 7693 does, in plain terms

Leo's Law This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.

Official summary by the Congressional Research Service, via Congress.gov.

Constitution Index

“VFA Constitution grade”

Not graded yet

H.R. 7693 has not been graded yet. New measures with an official summary are graded daily under the published rubric.

What should pass

“VFA SI Solution”

No solution yet

A sourced SI draft appears here once it passes automated checks (Constitution citation, source verification, independent SI critic). How publication works.

Share card

1200×675 PNG for X, Threads, LinkedIn and messages. Free to share with a link back to this page.

For journalists and bloggers

“Embed this grade”

Free to use with the link back. The badge and card update when the grade changes. Embed terms →

VFA Constitution grade for H.R. 7693

← Back to the Republic